We will conduct a randomized, placebo-controlled, double-blind, coronary angiographic/carotid ultrasonographic clinical trial of hormonal replacement therapy (HRT) in postmenopausal women. There will be three treatment arms: 1) Micronized 17beta-estradiol 1 mg per day (days 1-30); 2) Micronized 17beta-estradiol plus medroxyprogesterone acetate 5 mg per day (for 12 consecutive days); and 3) Usual care/placebo. All arms will receive lipid-lowering therapy, low-fat low cholesterol diet and pravastatin in sufficient dosage to reduce LDL-cholesterol levels below 130 mg/dL. This trial will evaluate both lipid and non-lipid effects of HRT on the coronary and carotid arterial wall under conditions which eliminate self-selection and differential interaction with the medical care system. Our study will draw from the large ethnically diverse population of greater Los Angeles. Two hundred and sixteen subjects will be randomized into a three year treatment trial with repeat coronary angiograms after three years. Coronary angiograms will be computer image processed to minimize measurement error for the primary trial outcome measure. There will be two secondary arterial outcome measures: 1) Global change score (GSC) derived from human panel read coronary angiograms; and 2) Ultrasound measures of common carotid arterial wall intima-media thickness (IMT). Clinical measures will include lipids, lipoproteins, apolipoproteins, estradiol and medroxyprogesterone levels, urinary prostanoid metabolites, and insulin/glucose metabolism. This angiographic/ultrasound clinical trial will allow us to study the direct arterial wall effects of two commonly prescribed hormonal replacement regimens, estrogen replacement therapy and cyclical progestin opposed estrogen replacement therapy. Hard data on this critical issue is needed for physicians to weigh the risk/benefit concerning HRT in postmenopausal women in order to set practice patterns.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL049298-03
Application #
2378785
Study Section
Clinical Trials Review Committee (CLTR)
Project Start
1995-03-13
Project End
2000-02-29
Budget Start
1997-04-15
Budget End
1998-02-28
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Künzli, Nino; Jerrett, Michael; Garcia-Esteban, Raquel et al. (2010) Ambient air pollution and the progression of atherosclerosis in adults. PLoS One 5:e9096
Gatto, Nicole M; Hodis, Howard N; Liu, Chao-Ran et al. (2008) Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease. Atherosclerosis 196:674-81
Steiner, Anne Z; Xiang, Min; Mack, Wendy J et al. (2007) Unopposed estradiol therapy in postmenopausal women: results from two randomized trials. Obstet Gynecol 109:581-7
Lord, Sarah J; Mack, Wendy J; Van Den Berg, David et al. (2005) Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Res 7:R336-44
Hodis, Howard N; Mack, Wendy J; Azen, Stanley P et al. (2003) Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 349:535-45
Slater, C C; Zhang, C; Hodis, H N et al. (2001) Comparison of estrogen and androgen levels after oral estrogen replacement therapy. J Reprod Med 46:1052-6
Wilcox, J G; Hwang, J; Hodis, H N et al. (1997) Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. Fertil Steril 67:57-62